Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|September 2, 2021
The road to chemotherapy-free treatment in chronic lymphocytic leukaemiaNil Albiol, Miguel Arguello-Tomas, Carol Moreno
Acta Haematologica|October 29, 2023
Frontline Therapy in Chronic Lymphocytic LeukemiaMiguel Arguello-Tomas, Nil Albiol, Carol Moreno
Cancer|December 11, 2025
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemiaMiguel Arguello-Tomas, Elionor Lynton-Pons, Nil Albiol, et al.
Leukemia & Lymphoma|July 15, 2023
Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European centerMiguel Arguello-Tomas, Nil Albiol, Paola Jara, et al.
Cancer|September 12, 2024
Risk scores predicting disease progression in early-stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracyMiguel Arguello-Tomas, Pablo Mozas, Nil Albiol, et al.
European Journal of Haematology|November 15, 2024
Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized TreatmentSara Redondo, María Costa, Maria-Estela Moreno-Martinez, et al.
Cancers|December 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL StudyPau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez, et al.
Transplantation and Cellular Therapy|April 22, 2023
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the LiteratureIrene García-Cadenas, Sara Redondo, Albert Esquirol, et al.
European Journal of Haematology|August 19, 2024
Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantationSara Redondo, Irene García-Cadenas, Albert Esquirol, et al.
European Journal of Haematology|April 14, 2023
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBISara Redondo, Irene García-Cadenas, Antonio Vila, et al.
Pageof 2